(S)-2-(3,4-dihydroxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)chroman-4-one

Catalog No. :
ACUCKF729
CAS No. :
30382-18-4
Molecular Formula :
C21H22O10
Molecular Weight :
434.40

IUPAC Name:(S)-2-(3,4-dihydroxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)chroman-4-one

(S)-2-(3,4-dihydroxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)chroman-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$541.00Login to see priceInquiryInquiry
5mg98%$1625.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-2-(3,4-dihydroxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)chroman-4-one
IUPAC Name(S)-2-(3,4-dihydroxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)chroman-4-one
Molecular FormulaC21H22O10
Molecular Weight434.40
SMILESO=C1C[C@@H](C2=CC=C(O)C(O)=C2)OC3=C1C=CC(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)=C3
InChI KeyAWENDZQUFCJISN-ZRWXNEIDSA-N
Synonym4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-7-(β-D-glucopyranosyloxy)-2,3-dihydro-, (2S)-;isocoreopsin;Isocoreopsin,Butin-7-O-β-D-glucopyranoside,Flavanocorepsin;4-dihydroxyphenyl)-7-(β-D-glucopyranosyloxy)-2;Flavanocorepsin
CAS No.30382-18-4

Synthetic Route by SureRoute

1. ACUCKF729 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUCKF729 route product structure diagram
    ACUCKF72930382-18-4
Inquiry

2. ACUCKF729 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUCKF729 route product structure diagram
    ACUCKF72930382-18-4
Inquiry

Comments (0)